As a key member in the MAPK signaling pathway, MAPK9 is also correlated with several diseases, including non-small-cell lung carcinoma [21], haemophilia A [22], and type I diabetes [23]. This evidence concerns the gene MAPK9 and non-small cell lung carcinoma.